Clinical Trials Browser

Esophageal Squamous Cell Carcinoma

NCT04338191 2023-12-27

FANTASTIC

Phase 3 Unknown

638 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04714190 2023-12-21

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

Phase 3 Unknown

351 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05081687 2023-10-11

BRAZIL-TNT

Phase 3 Unknown

150 enrolled

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT04358354 2021-07-19

Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer

Phase 3 Unknown

388 enrolled

Gastrointestinal

Stomach Neoplasms

NCT04486651 2021-01-28

HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer

Phase 3 Unknown

560 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02339116 2020-02-05

TRIBE2

Phase 3 Unknown

654 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03771846 2019-12-05

HAIC Versus Systemic Chemotherapy for Unresectable ICC

Phase 3 Unknown

188 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT03522649 2019-06-18

A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

668 enrolled

Gastrointestinal

Previously Treated Metastatic Colorectal Cancer

NCT02087475 2019-06-05

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

Phase 3 Unknown

360 enrolled

Gastrointestinal

Neoplasm Metastasis, Neoplasm Recurrence, Local, Colorectal Neoplasms

NCT03651219 2018-08-29

Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer

Phase 3 Unknown

90 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT03061058 2017-09-15

Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC

Phase 3 Unknown

240 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02935764 2016-10-17

FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

Phase 3 Unknown

164 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02319187 2015-08-03

Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial

Phase 3 Unknown

240 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00433927 2014-03-14

5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

Phase 3 Unknown

568 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00021281 2013-12-19

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00797485 2013-08-26

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Phase 3 Unknown

672 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01501669 2012-07-18

PROCEED

Phase 3 Unknown

222 enrolled

Breast

Breast Neoplasms

NCT01566942 2012-03-30

FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer

Phase 3 Unknown

200 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01249638 2011-03-14

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Phase 3 Unknown

516 enrolled

Gastrointestinal

Colorectal Cancer Metastatic

NCT01224652 2010-10-20

Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy

Phase 3 Unknown

518 enrolled

Gastrointestinal

Stomach Neoplasms

NCT00091312 2009-02-09

Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Phase 3 Unknown

1,976 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00003260 2009-01-13

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Phase 3 Unknown

109 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00189657 2005-09-19

5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer

Phase 3 Unknown

Gastrointestinal

Rectal Neoplasms

Clinical Trials

Escape

FANTASTIC

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

BRAZIL-TNT

Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer

HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer

TRIBE2

HAIC Versus Systemic Chemotherapy for Unresectable ICC

A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer

Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC

FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial

5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

PROCEED

FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy

Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer